Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Presentation Icons

Live Streamed

On Demand

Back

346 Views

Session: Infections in Transplant and Hematologic Malignancy Patients, Part 2

632 - Cytomegalovirus Infections in Patients with Relapsed/Refractory Multiple Myeloma on Novel T-Cell Redirecting Therapy

Saturday, October 19, 2024

3:15 PM – 3:30 PM US PT

Location: 404 AB

Presenting Author(s)

Jennifer Makhoul, MD (she/her/hers)

Fellow / Dr.
University of Texas Health Science Center at Houston/MD Anderson Cancer Center
Houston, TX, United States

Slides

Co-Author(s)

SJ

Silpa Jetty, MD

University of Texas Health Science Center at Houston/MD Anderson Cancer Center
Houston, Texas, United States
FK

Fareed Khawaja, MBBS

Assistant Professor
The University of Texas MD Anderson Cancer Center
Houston, Texas, United States
KP

Krina Patel, MD

Associate Professor
MD Anderson Cancer Center
Houston, Texas, United States
HL

Hans C. Lee, MD

Associate Professor
The University of Texas MD Anderson Cancer Center
Houston, Texas, United States
SH

Sandra Horowitz, PharmD

UT MD Anderson Cancer Center
Houston, Texas, United States
AS

Amy Spallone, M.D.

University of Texas MD Anderson Cancer Center
Houston, Texas, United States
Ella Ariza Heredia, MD

Associate Professor
The University of Texas MD Anderson Cancer Center
Houston, Texas, United States
Roy F. Chemaly, MD/MPH (he/him/his)

Gerald P Bodey, Sr Distinguished Professor of Infectious Diseases
University of Texas MD Anderson Cancer Center
Houston, TX, United States

Disclosure(s):

Jennifer Makhoul, MD: No financial relationships to disclose

Silpa Jetty, MD: No financial relationships to disclose

Fareed Khawaja, MBBS: Eurofins Viracor: Grant/Research Support; Symbio: Grant/Research Support

Krina Patel, MD: Abbvie: Advisor/Consultant; Arcellx: Advisor/Consultant; Astra Zeneca: Advisor/Consultant; BMS: Advisor/Consultant, Scientific committee/chair; Caribou Sciences: Advisor/Consultant; Celgene: Advisor/Consultant; Genentech: Advisor/Consultant; Janssen: Advisor/Consultant; Kite: Advisor/Consultant, Scientific committee/chair; Merck: Advisor/Consultant; Oricel: Scientific committee/chair; Pfizer: Advisor/Consultant; Regeneron: Advisor/Consultant; Sanofi: Advisor/Consultant

Hans C. Lee, MD: Abbvie: Advisor/Consultant; Allogene Therapeutics: Advisor/Consultant; Bristol Myers Squibb: Advisor/Consultant, Grant/Research Support; Genentech: Advisor/Consultant; GlaxoSmithKline: Advisor/Consultant, Grant/Research Support; Janssen: Advisor/Consultant, Grant/Research Support; Regeneneron: Advisor/Consultant, Grant/Research Support; Sanofi: Advisor/Consultant; Takeda Pharmaceuticals: Advisor/Consultant, Grant/Research Support

Sandra Horowitz, PharmD: No financial relationships to disclose

Amy Spallone, M.D.: No financial relationships to disclose

Ella Ariza Heredia, MD: No financial relationships to disclose

Roy F. Chemaly, MD/MPH: AiCuris: Advisor/Consultant, Grant/Research Support; Ansun Pharmaceuticals: Advisor/Consultant, Grant/Research Support; Astellas: Advisor/Consultant; Eurofins-Viracor: Grant/Research Support; InflaRX: Advisor/Consultant; Janssen: Advisor/Consultant; Karius: Advisor/Consultant, Grant/Research Support; Merck/MSD: Advisor/Consultant, Grant/Research Support; Moderna: Advisor/Consultant; Oxford Immunotec: Advisor/Consultant, Grant/Research Support; Roche/Genentech: Advisor/Consultant, Grant/Research Support; Shinogi: Advisor/Consultant; Takeda: Advisor/Consultant, Grant/Research Support; Tether: Advisor/Consultant